Replies to post #8872 on Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

I admit and agree that of ALL countries to run a clinical trial for COVID-19 South Korea appears to have a diminishing return of patients (the short draw). Japan is spiking back up. Ifenprodil is already approved in Japan for use. It seems logical - but again I'm not a tri-level chess player like those guys. However, if Algernon can't get trials up and running in Canada ASAP (By Any Means Necessary) where else on the planet is possible? Maybe I missed something in the last BioPub webcast? I'll be honest, I never gave it a full review. I got sidetracked by the trading halt and all the news. Nothing comes EZ, and definitely not in nano cap penny land.

My head is hurting now. I can't tell if it's penny world exhaustion or this red wine from Argentina. Maybe I should take some Ifenprodil?



I think I'll just drink more wine.

/////AMG

$AGNPF